In mid-August, the Bio-Techne team shared their vast industry expertise in a webinar focusing on recombinant protein selection, customization and application. The featured panelists—Bio-Techne’s Martin Ramsden, Director Commercial Development and John Humphrey, Director Molecular and Cellular Biology—presented on recombinant protein applications, specifically biotinylated proteins, including site-specific Avi-tag biotinylation. Humphrey also spoke at length about COVID-19 SARS proteins available through Bio-Techne. Below is the recording of the full live webinar and Q&A session.

> If you have questions for Bio-Techne or R&D Systems, you can email them at or access their supplier page on

> If you are interested in hosting a webinar with, please contact us at